Assembly Biosciences (ASMB) CSO granted 14,000 RSUs tied to plan amendment
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Assembly Biosciences Chief Scientific Officer awarded RSUs. Chief Scientific Officer William E. Delaney IV received a grant of 14,000 restricted stock units of common stock at no cash cost, representing 35% of his annual equity grant. The award was contingent on stockholder approval of an amendment to the company’s 2018 Stock Incentive Plan and became issuable after that approval on June 4, 2026. The RSUs vest in four approximately equal annual installments on March 29, 2027, 2028, 2029, and 2030, assuming continued service. Following this award, he directly holds 60,330 shares of common stock, including 688 shares acquired through the employee stock purchase plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Delaney William E IV
Role
Chief Scientific Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 14,000 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 60,330 shares (Direct, null)
Footnotes (1)
- Restricted stock units ("RSUs") representing 35% of the reporting person's annual equity grant, which was approved on March 29, 2026 and was contingent upon stockholder approval of an amendment to the Issuer's Amended and Restated 2018 Stock Incentive Plan (the "Plan") that increased the number of shares of common stock authorized for issuance under the Plan (the "Plan Amendment"). Although the RSUs were granted on March 29, 2026, the RSUs became issuable upon stockholder approval of the Plan Amendment on June 4, 2026 and vest in four approximately equal installments, assuming continuous service on each vesting date, as follows: March 29, 2027; March 29, 2028; March 29, 2029; and March 29, 2030. Includes 688 shares acquired under the Assembly Biosciences, Inc. Second Amended and Restated 2018 Employee Stock Purchase Plan on May 14, 2026.
Key Figures
RSU grant size: 14,000 RSUs
Grant price: $0.0000 per share
Portion of annual equity grant: 35%
+4 more
7 metrics
RSU grant size
14,000 RSUs
Grant to Chief Scientific Officer on March 29, 2026
Grant price
$0.0000 per share
RSUs awarded at no cash cost
Portion of annual equity grant
35%
RSUs as share of annual equity award
Shares after transaction
60,330 shares
Direct holdings following RSU grant
ESPP shares included
688 shares
Acquired May 14, 2026 under Employee Stock Purchase Plan
RSU vesting dates
2027, 2028, 2029, 2030
Four approximately equal annual installments starting March 29, 2027
Plan amendment approval date
June 4, 2026
Stockholder approval making RSUs issuable
Key Terms
Restricted stock units ("RSUs"), Amended and Restated 2018 Stock Incentive Plan, Plan Amendment, Employee Stock Purchase Plan
4 terms
Restricted stock units ("RSUs") financial
"Restricted stock units ("RSUs") representing 35% of the reporting person's annual equity grant"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Amended and Restated 2018 Stock Incentive Plan financial
"amendment to the Issuer's Amended and Restated 2018 Stock Incentive Plan"
Plan Amendment financial
"the Plan Amendment that increased the number of shares of common stock authorized for issuance"
Employee Stock Purchase Plan financial
"acquired under the Assembly Biosciences, Inc. Second Amended and Restated 2018 Employee Stock Purchase Plan"
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
FAQ
What did ASMB Chief Scientific Officer William E. Delaney IV receive in this Form 4?
William E. Delaney IV received a grant of 14,000 restricted stock units of Assembly Biosciences common stock. The grant represents 35% of his annual equity award and was issued at no cash cost as part of his compensation package.
How do the new RSUs for ASMB’s Chief Scientific Officer vest over time?
The 14,000 restricted stock units vest in four approximately equal annual installments. Vesting dates are March 29, 2027, March 29, 2028, March 29, 2029, and March 29, 2030, and each installment requires the executive’s continuous service through that date.
What approvals were required for the ASMB RSU grant reported in this Form 4?
The RSU grant was contingent on stockholder approval of an amendment to Assembly Biosciences’ Amended and Restated 2018 Stock Incentive Plan. This Plan Amendment increased the shares authorized for issuance and was approved on June 4, 2026, making the RSUs issuable.
What role does the ASMB 2018 Stock Incentive Plan play in this Form 4 transaction?
The RSUs come from Assembly Biosciences’ Amended and Restated 2018 Stock Incentive Plan. A Plan Amendment, approved by stockholders on June 4, 2026, increased authorized shares and was required before the 14,000 RSUs could become issuable to the Chief Scientific Officer.